Skip Nav Destination
Close Modal
Update search
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Issue Section
Date
Availability
1-10 of 10
Keywords: Myocardial infarction
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
Uwe Zeymer, Harry Suryapranata, Jean Pierre Monassier, Grzegorz Opolski, John Davies, Gundars Rasmanis, Ulrich Tebbe, Rolf Schröder, Marie-Louise Willberg, Rolf Tiemann, Thomas Machnig, Karl-Ludwig Neuhaus
Journal:
Heart Drug
Heart Drug (2001) 1 (2): 71–76.
Published Online: 17 November 2004
... infarct size in experimental infarct models. Objective: The objective of the ESCAMI trial is to investigate the tolerability and cardioprotective efficacy of eniporide as an adjunct to reperfusion therapy in patients with acute myocardial infarction (AMI) compared to reperfusion therapy alone. Methods...
Journal Articles
Journal:
Heart Drug
Heart Drug (2003) 3 (3): 153–158.
Published Online: 21 November 2003
... to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. 2003 Heart failure Myocardial infarction Urotensin II Vasoconstrictor peptide Review Heart Drug 2003;3:153 158 DOI: 10.1159/000072742 Received: March 10, 2003...
Journal Articles
W.B. Nielsen, J.K. Madsen, P. Grande, K. Saunamäki, P. Thayssen, E. Kassis, U. Eriksen, J. Aarøe, S. Haunsø, T.T. Nielsen, T.H. Haghfelt
Journal:
Heart Drug
Heart Drug (2002) 2 (3): 110–116.
Published Online: 25 July 2002
...W.B. Nielsen; J.K. Madsen; P. Grande; K. Saunamäki; P. Thayssen; E. Kassis; U. Eriksen; J. Aarøe; S. Haunsø; T.T. Nielsen; T.H. Haghfelt Background: The significance of silent ischemia after acute myocardial infarction (MI) has been questioned. Objective: The aim of this study was to assess...
Journal Articles
Journal:
Heart Drug
Heart Drug (2001) 1 (6): 332–340.
Published Online: 08 February 2002
... and efficient adjunct to the current therapeutic approach to the acute coronary syndrome. Further well-designed and carefully conducted clinical trials should elucidate the potential benefits of SSRI in an expanding array of clinical conditions, including myocardial infarction and unstable angina...
Journal Articles
Mustafa Taskiran, Klaus Klausen, Karen Kornerup, Bo Feldt-Rasmussen, Gorm B. Jensen, Jan Skov Jensen
Journal:
Heart Drug
Heart Drug (2001) 1 (6): 305–309.
Published Online: 08 February 2002
...Mustafa Taskiran; Klaus Klausen; Karen Kornerup; Bo Feldt-Rasmussen; Gorm B. Jensen; Jan Skov Jensen In order to study the long-term effect of microalbuminuria on mortality among patients hospitalized with acute myocardial infarction, we followed 125 patients from 1996 to 2000. Exclusion criteria...
Journal Articles
Journal:
Heart Drug
Heart Drug (2001) 1 (5): 255–259.
Published Online: 21 January 2002
... to in the content or advertisements. Myocardial infarction Ventricular septal defect Cardiac remodeling Coronary artery disease Clinical Study Heart Drug 2001;1:255 259 Received: July 4, 2001 Accepted after revision: September 10, 2001 Surgical Management of Postinfarction Ventricular Septal Rupture...
Journal Articles
Journal:
Heart Drug
Heart Drug (2001) 1 (4): 197–206.
Published Online: 31 October 2001
...Benedikte Haastrup; Sabine Gill; Torben Haghfelt; Mogens Hørder; Søren Risom Kristensen Background: Thrombolytic therapy often fails to obtain reperfusion in acute myocardial infarction (AMI). To allow further intervention, various methods for non-invasive reperfusion assessment, e.g. release...
Journal Articles
Søren Boesgaard, Nicolai Gruhn, Michael C.J. Wanscher, Kaare M. Sander, Svend A. Mortensen, Jan Aldershvile
Journal:
Heart Drug
Heart Drug (2001) 1 (3): 176–181.
Published Online: 31 July 2001
...Søren Boesgaard; Nicolai Gruhn; Michael C.J. Wanscher; Kaare M. Sander; Svend A. Mortensen; Jan Aldershvile Even though treatments of both acute myocardial infarction (MI) and congestive heart failure have improved substantially, the management of cardiogenic shock following acute MI remains...
Journal Articles
Heinz Theres, Jana Binkau, Parwis Fotuhi, Robert Flieger, Tino Schneider, Klaus-Dieter Wernecke, Gert Baumann
Journal:
Heart Drug
Heart Drug (2000) 1 (1): 20–25.
Published Online: 12 March 2001
... with symptoms of heart failure after acute myocardial infarction. Long-term treatment strategies for low-risk patients after acute myocardial infarction have not as yet been elucidated by clinical studies. Objective: The objective of this study is to deliver evidence of a possible additional, long-term effect...
Journal Articles
Journal:
Heart Drug
Heart Drug (2000) 1 (1): 52–55.
Published Online: 12 March 2001
...Ian B.A. Menown; A.A. Jennifer Adgey The efficacy of fibrinolytic therapy in acute myocardial infarction may be limited by three factors: failure to achieve reperfusion of the epicardial culprit artery, failure to achieve myocardial reperfusion, or reocclusion of the culprit artery following...